Nerinetide (Neuroprotection)

Type: drug

Status: Investigational (Canada trial leader)

Developer: NoNO Inc.

Breakthrough Summary

No summary available.

Mechanism of Action

PSD-95 inhibitor that protects neurons during ischaemia

Year: 2024-2026